Tax, Education and Patent Reform Necessary for Biomedical Industry to Remain Globally Competitive, Finds California Healthcare Institute and PricewaterhouseCoopers

Business Wire, Jan 24, 2008

Methodology

CHI worked with PricewaterhouseCoopers LLP to collect and administer data for the 2008 CHI/PwC California Biomedical Industry Survey. The survey was conducted in 2007 and targeted approximately 1,500 companies that conduct business in California in the areas of pharmaceuticals, biotechnology, medical devices, diagnostics or medical equipment.

About the California Healthcare Institute

The California Healthcare Institute (www.chi.org) is a non-profit public policy research organization for California's biomedical R&D industry. CHI represents more than 250 leading medical device, biotechnology, diagnostics and pharmaceutical companies and public and private academic biomedical research organizations. CHI's mission is to advance responsible public policies that foster medical innovation and promote scientific discovery.

About PricewaterhouseCoopers

PricewaterhouseCoopers (www.pwc.com) provides industry-focused assurance, tax and advisory services to build public trust and enhance value for its clients and their stakeholders. More than 146,000 people in 150 countries across our network share their thinking, experience and solutions to develop fresh perspectives and practical advice.

(c) 2008 PricewaterhouseCoopers LLP (US). All rights reserved. "PricewaterhouseCoopers" refers to PricewaterhouseCoopers LLP (US), a Delaware limited liability partnership, or, as the context requires, the PricewaterhouseCoopers global network or other member firms of the network, each of which is a separate and independent legal entity.